Systemic sclerosis (scleroderma) trials in China

In China 65 Also abroad 224

62 of 65 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Early phase 1Taking people
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
Where
Deyang
Age
18 years to 65 years
People
6
Run by
CytoCares Inc
See details and how to joinNCT07193810
Early phase 1Taking people
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
Where
Hangzhou
Age
3 years and over
People
15
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07507201
No phaseTaking people
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Where
Wuhan
Age
18 years to 70 years
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470151
Phase 1Taking people
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
Where
Beijing
Age
18 years to 60 years
People
27
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06822881
Early phase 1Taking people
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
Where
Bengbu
Age
18 years to 70 years
People
20
Run by
Nanjing Bioheng Biotech Co., Ltd.
See details and how to joinNCT06548607
Phase 1/2Taking people
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Where
Beijing
Age
6 years to 65 years
People
45
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06947473
Phase 1Taking people
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Where
Xuzhou
Age
18 years to 65 years
People
18
Run by
China Immunotech (Beijing) Biotechnology Co., Ltd.
See details and how to joinNCT07236801
Phase 1Not yet taking people in China
YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases
Where
Shanghai
Age
5 years to 18 years
People
12
Run by
Children's Hospital of Fudan University
See details and how to joinNCT07439029
Early phase 1Taking people
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Where
Shanghai
Age
18 years to 70 years
People
60
Run by
Changhai Hospital
See details and how to joinNCT07246096
Phase 1Taking people
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
Where
Hangzhou
Age
3 years and over
People
15
Run by
The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07305116
Early phase 1Taking people
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
Where
Lianyungang
Age
18 years to 70 years
People
18
Run by
Nanjing Bioheng Biotech Co., Ltd.
See details and how to joinNCT06775912
No phaseTaking people
Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis
Where
Guangzhou, Shanghai
Age
18 years to 70 years
People
48
Run by
Cytori Therapeutics
See details and how to joinNCT07360808
Early phase 1Taking people
Safety, Efficacy and Cellular Metabolic Dynamics of CT1195E in Patients With Refractory / Progressive SSC
Where
Wuhan
Age
18 years to 60 years
People
12
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07355972
Phase 1Taking people
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Where
Tianjin
Age
18 years and over
People
12
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07315087
No phaseTaking people
Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
Where
Hangzhou
Age
18 years to 65 years
People
15
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06614270
No phaseNot yet taking people in China
A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases
Where
Tianjin
Age
18 years to 65 years
People
24
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07212322
Phase 1Taking people
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Where
Tianjin
Age
18 years and over
People
12
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06941129
Phase 1Taking people
Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Where
Hangzhou
Age
5 years and over
People
11
Run by
Chongqing Precision Biotech Co., Ltd
See details and how to joinNCT07184450
Early phase 1Taking people
Safety Study of CC312 in Autoimmune Disease Patients
Where
Tianjin
Age
18 years and over
People
18
Run by
CytoCares Inc
See details and how to joinNCT06888960
Phase 1Taking people
A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases
Where
Beijing
Age
18 years to 65 years
People
44
Run by
Beijing GoBroad Hospital
See details and how to joinNCT07167537
No phaseTaking people
Anti CD19/BCMA CAR Gene Therapy for Autoimmune Diseases
Where
Hefei
Age
18 years and over
People
18
Run by
Anhui Provincial Hospital
See details and how to joinNCT07121777
Phase 1Taking people
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
Where
Shanghai
Age
18 years to 70 years
People
30
Run by
RenJi Hospital
See details and how to joinNCT06249438
Early phase 1Taking people
The Clinical Study on the Treatment of SSc With UTAA91 Injection.
Where
Wuhan
Age
18 years and over
People
24
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07000682
No phaseTaking people
CAR-T Cells Therapy for Patients With Autoimmune Diseases
Where
Hefei
Age
18 years and over
People
18
Run by
Anhui Provincial Hospital
See details and how to joinNCT07052565
Early phase 1Not yet taking people in China
Clinical Study on the Treatment of Systemic Sclerosis With UTAA91 Injection.
Where
Wuhan
Age
18 years and over
People
24
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT06982534